Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.

Clinical trial NCT07303387 · RECRUITING

Trial details

NCT number: NCT07303387
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor Malignancies Clear Cell Endometrial Carcinoma Ovarian Cancer

Start date: 2026-03-05
Primary completion: 2031-02-28
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.